1H-imidazole, 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-,
antipamezole,
atipamezole,
MPV 1248,
MPV-1248,
Atipamezole,
104054-27-5,
Antisedan,
MPV 1248,
MPV-1248,
4-(2-Ethyl-2-indanyl)imidazole,
4-(2-ethyl-2,3-dihydro-1h-inden-2-yl)-1h-imidazole,
Atipamezol [Spanish],
Atipamezolum [Latin],
UNII-03N9U5JAF6,
1H-Imidazole, 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-,
03N9U5JAF6,
MPV1248,
5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole,
NCGC00182707-01,
Zeolite, type: ZSM-5,
DSSTox_CID_29061,
DSSTox_RID_83274,
DSSTox_GSID_49135,
5-(2-ethyl-1,3-dihydroinden-2-yl)-1H-imidazole,
antipamezole,
Atipamezol,
Atipamezolum,
C14H16N2,
4-(2-ethyl-2-indanyl)imidazole; 4-(2-ethyl-2,3-dihydro-1h-inden-2-yl)-1h-imidazole,
308081-08-5,
CAS-104054-27-5,
NCGC00182707-02,
Atipamezole; MPV-1248,
Atipamezole [USAN:BAN:INN],
Atipamezole [USAN:INN:BAN],
Antisedan (TN),
PubChem21912,
Zeolite,type: ZSM-5,
ACMC-20bb9y,
AC1L2FXQ,
AC1Q4WOE,
Atipamezole (USAN/INN),
SCHEMBL304971,
CHEMBL353972,
DTXSID2049135,
Atipamezole, >=98% (HPLC),
BDBM81807,
CTK4A2660,
BCP02215,
EBD30510,
ZINC5424171,
Tox21_113005,
HY-12380A,
MFCD00864502,
NSC_71310,
PDSP1_001582,
PDSP2_001566,
s4650,
AKOS015900246,
AKOS032960366,
Tox21_113005_1,
5-(2-ethylindan-2-yl)-1H-imidazole,
AC-1614,
CS-3390,
RL00197,
NCGC00182707-03,
AN-14783,
BC226060,
SC-21403,
SC-27035,
LS-171901,
AK01050723,
CAS_104054-27-5,
FT-0603697,
A26271,
D03002,
054A275,
L000823,
SR-01000944943,
I14-1027,
J-513300,
SR-01000944943-1,
1H-Imidazole, 5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-,
Atipamezole hydrochloride,
D05OVC,
CID71310,
AR-1F5883,
4(5)-(2-ethyl-2-indanyl)imidazole,
ACN-049657,
C14-H16-N2,
C050701,
104075-48-1,
104715-83-5,